Results from Diamyd Study in 70 Children with Autoimmune Type 1 Diabetes to be Presented at the European Diabetes Meeting
May 23, 2006 12:48 ET
|
Diamyd Medical AB
STOCKHOLM, Sweden, May 23, 2006 (PRIMEZONE) -- Diamyd Medical AB (Other OTC:DMYDF) (Stockholm:DIAMB) announced today that results from studies with the Diamyd(tm) therapeutic for autoimmune diabetes...
Khandaker Partners to Initiate Coverage of Diamyd Medical
May 12, 2006 10:00 ET
|
Diamyd Medical AB
STOCKHOLM, Sweden, May 12, 2006 (PRIMEZONE) -- Diamyd Medical AB (Stockholm:DIAMB) (Other OTC:DMYDF) with its lead drug candidate for diabetes in Phase IIb trials, announced today that Khandaker...
Interim Report for Diamyd Medical AB
April 20, 2006 11:36 ET
|
Diamyd Medical AB
STOCKHOLM, Sweden, April 20, 2006 (PRIMEZONE) -- Diamyd Medical AB (Other OTC:DMYDF), a biotechnology company focused on the treatment of diabetes and its complications, including chronic pain and...
Diamyd Medical AB Launches Level I American Depositary Receipt Program on April 20
April 19, 2006 12:02 ET
|
Diamyd Medical AB
STOCKHOLM, Sweden, April 19, 2006 (PRIMEZONE) -- Diamyd Medical AB (Other OTC:DMYDF) (OMX:DIAMB), a biotechnology company focused on the treatment of diabetes and its complications today announced...
Diamyd Medical To Participate in Seattle-Sweden Childhood Diabetes Awareness Day Event
March 28, 2006 11:22 ET
|
Diamyd Medical AB
STOCKHOLD, Sweden, March 28, 2006 (PRIMEZONE) -- Diamyd Medical AB (Other OTC:DMYDF) (OMX:DIAMB), along with local institutions, will sponsor the first Seattle-Sweden Childhood Diabetes Awareness Day...
Interim Report for Diamyd Medical AB
January 20, 2006 16:18 ET
|
Diamyd Medical AB
STOCKHOLM, Sweden, Jan. 20, 2006 (PRIMEZONE) -- Diamyd Medical AB (Pink Sheets:DMYDF), a global biotechnology company focused on the treatment of diabetes and its complications, including chronic pain...
Diamyd Medical Appoints Protein Sciences 'USA' for Production of Its Lead Therapeutic Diabetes Vaccine for Phase III-Trials and to Submit an IND to the FDA
December 19, 2005 11:34 ET
|
Diamyd Medical AB
STOCKHOLM, Sweden, Dec. 19, 2005 (PRIMEZONE) -- Diamyd Medical AB (OMX:DIAMB) today announced that is has reached an agreement with Protein Sciences Corporation, a Meriden, CT-based biopharmaceutical...
Diamyd Medical Demonstrates Safety of New GAD Formulation in Pre-Clinical Study
December 15, 2005 08:57 ET
|
Diamyd Medical AB
STOCKHOLM, Sweden, Dec. 15, 2005 (PRIMEZONE) -- Diamyd Medical AB (OMX:DIAMB) today announced the successful results of a pre-clinical study demonstrating the safety and tolerability of a novel...
Diamyd Medical Broadens Diabetes Pipeline With Acquisition Of Nurel Therapeutics
December 13, 2005 10:15 ET
|
Diamyd Medical AB
STOCKHOLM, Sweden, Dec. 13, 2005 (PRIMEZONE) -- Diamyd Medical AB (OMX:DIAMB) emerged as a global biotechnology company as shareholders approved the acquisition of Nurel Therapeutics, Inc. at a...
Diamyd Acquires American Biotechnology Company Nurel Therapeutics, Inc.
November 22, 2005 09:55 ET
|
Diamyd Medical AB
STOCKHOLM, Sweden, Nov. 22, 2005 (PRIMEZONE) -- Diamyd Medical AB (OMX:DIAMB), today announced that it has agreed to acquire all of the outstanding shares in Nurel, a Pittsburgh, PA-based...